Care Juncture | Outcome | Analysis used | N | Significant Factors at p < 0.05 | |||||
Factor | β/OR/ RR/IRR | 95% CI lower | 95% CI upper | p-value | |||||
Diagnosis and Evaluation | E&M visita | N/Aa | 418 | - | - | - | - | - | |
Days to E&M visit | GLM- Gamma | 404 (missing n = 14) | Marital status Unknown (vs. Married) | 1.589 | 1.108 | 2.278 | 0.0119 | ||
Treatment Plan Design | Treatment Plan | Logistic | Y = 373, N = 31 | Number of metastatic sites | 1.775 | 1.118 | 2.817 | 0.0150 | |
Days to Treatment Plan date | GLM- Gamma | 373 | Residential segregation index for black/whiteb | 1.024 | 1.006 | 1.044 | 0.0102 | ||
Distress Screening | Logistic | Y = 353, N = 51 | Age at diagnosis | 0.961 | 0.927 | 0.997 | 0.0338 | ||
Marital status Unknown (vs. Married) | 0.323 | 0.113 | 0.926 | 0.0354 | |||||
Days to Distress Screening date | GLM- normal | 353 | Age at diagnosis | 0.0000056 | 0.000000025 | 0.001 | < 0.001 | ||
Treatment Implementation | Anticancer Therapy Start | Logistic | Y = 372, N = 32 | Number of metastatic sites | 1.686 | 1.088 | 2.613 | 0.0195 | |
Days to Anticancer Therapy date | GLM- Gamma | 368c | None | - | - | - | - | ||
Radiation Start | Logistic | Y = 76, N = 328 | None | - | - | - | - | ||
Days to Radiation dated | N/Ad | 76 | - | - | - | - | - | ||
Surgery Start | Logistic | Y = 43, N = 361 | Age at diagnosis | 0.957 | 0.922 | 0.994 | 0.0238 | ||
Days to Surgery dated | N/Ad | 43 | - | - | - | - | - | ||
ACP visit | Logistic | Y = 136, N = 268 | None | - | - | - | - | ||
Days to ACP date | GLM- Gamma | 136 | Access to other primary care providers | 0.9993 | 0.9988 | 0.9998 | 0.0095 | ||
End of Life Care | Palliative Care | Logistic | Y = 14, N = 390 | Age at diagnosis | 0.906 | 0.840 | 0.977 | 0.0101 | |
Days to Palliative Care referrald | N/Ad | 14 | - | - | - | - | - | ||
Hospice Enrollment | Logistic | Y = 128, N = 89 | None | - | - | - | - | ||
Days to Hospice Enrollment date | GLM- Poisson | 128 | Race/ethnicity–Black (vs. White) | 0.868 | 0.845 | 0.891 | < 0.0001 | ||
Race/ethnicity–Hispanic (vs. White) | 0.652 | 0.635 | 0.671 | < 0.0001 | |||||
Age at diagnosis | 0.971 | 0.970 | 0.972 | < 0.0001 | |||||
Marital – Divorced (vs. married) | 0.723 | 0.704 | 0.743 | < 0.0001 | |||||
Marital – Single (vs. married) | 0.741 | 0.725 | 0.758 | < 0.0001 | |||||
Marital – Widowed (vs. married) | 0.935 | 0.919 | 0.952 | < 0.0001 | |||||
Marital – Unknown (vs. married) | 0.606 | 0.582 | 0.630 | < 0.0001 | |||||
No. of metastatic sites | 0.991 | 0.986 | 0.996 | 0.0003 | |||||
Access to primary care | 1.0001 | 1.0001 | 1.0001 | < 0.0001 | |||||
High school completion | 1.416 | 1.129 | 1.775 | 0.0026 | |||||
Access to other primary care providers | 0.9999 | 0.9999 | 0.9999 | < 0.0001 | |||||
Residential segregation index for black/white | 1.0086 | 1.0077 | 1.0094 | < 0.0001 | |||||
Residential segregation index for white/non-white | 0.982 | 0.981 | 0.983 | < 0.0001 | |||||
Chemotherapy within 14 days of deathd | N/Ad | 18 | - | - | - | - | - | ||
Hospice Length of Stay (LOS) | GLM- Poisson | 82e | Race/ethnicity – Black (vs. White) | 0.754 | 0.645 | 0.882 | 0.0004 | ||
Race/ethnicity – Hispanic (vs. White) | 0.747 | 0.632 | 0.882 | 0.0006 | |||||
Age at diagnosis | 1.010 | 1.006 | 1.015 | < 0.0001 | |||||
Marital – Divorced (vs. married) | 2.094 | 1.855 | 2.364 | < 0.0001 | |||||
Marital – Widowed (vs. married) | 0.833 | 0.734 | 0.946 | 0.0048 | |||||
No. of metastatic sites | 0.871 | 0.842 | 0.901 | < 0.0001 | |||||
Access to primary care | 1.0001 | 1.000 | 1.0001 | 0.015 | |||||
High school completion | 6.346 | 1.794 | 22.457 | 0.0042 | |||||
Access to other primary care providers | 0.9999 | 0.9998 | 1.0000 | 0.0014 | |||||
Residential segregation index for black/white | 1.027 | 1.021 | 1.033 | < 0.0001 |